Abstract
Complications of pheochromocytoma, such as hypertensive emergency, can be critical. Clinicians should recognize that pheochromocytoma is not uncommon in patients with large adrenal tumors, and screening should be undertaken prior to any intervention.
Keywords: 123I‐metaiodobenzylguanidine scintigraphy, pheochromocytoma, primary care
Complications of pheochromocytoma, such as hypertensive emergency, can be critical. Clinicians should recognize that pheochromocytoma is not uncommon in patients with large adrenal tumors, and screening should be undertaken prior to any intervention.
1. CASE
A 63‐year‐old woman without any medical history was referred to our hospital by a primary care doctor due to an adrenal tumor and hypertensive urgency. On admission, her blood pressure was 255/164 mm Hg, but she was otherwise asymptomatic. The catecholamine levels in her plasma (adrenaline, 3.92 ng/mL; noradrenaline, 3.91 ng/mL; dopamine, 0.05 ng/mL) and urine (metanephrine, 29.63 mg/day; normetanephrine, 13.19 mg/day; vanillylmandelic acid, 91.8 mg/day) were markedly elevated. Abdominal ultrasonography revealed a massive hypovascular, heterogeneous mass in the left adrenal gland (Figure 1A). Abdominal computed tomography revealed a 10‐cm mass (Figure 1B), and abdominal fat‐suppression T2‐weighted magnetic resonance imaging showed a well‐circumscribed tumor (Figure 1C). 123I‐metaiodobenzylguanidine scintigraphy revealed intense uptake in the left adrenal tumor (Figure 1D, 1E). Based on these findings, the patient was diagnosed with a massive pheochromocytoma. We started administering oral doxazosin and performed laparoscopic left adrenalectomy thereafter. She became normotensive after the surgery.
Pheochromocytoma is a catecholamine‐producing tumor originating in the sympathetic nervous system; it is found in less than 0.2% of patients with hypertension. 1 Incidence rate of pheochromocytoma was reportedly 0.8 per 100 000 person‐years. 2 Because there are critical complications such as hypertensive emergency with the disease, early diagnosis of pheochromocytoma is imperative. In particular, pheochromocytoma is not uncommon in patients with large adrenal tumors, and screening for the disease should be undertaken prior to any intervention as of this case.
CONFLICT OF INTEREST
None declared.
AUTHOR CONTRIBUTIONS
TA, KO, and YN: wrote the first draft and managed all the submission process. YY, HH, and FO: contributed to the clinical management of the patients and revised the manuscript.
ACKNOWLEDGMENTS
Published with written consent of the patient.
Anai T, Oka K, Yokota Y, Nishimura Y, Hagiya H, Otsuka F. Massive pheochromocytoma. Clin Case Rep. 2020;8:2308–2309. 10.1002/ccr3.3124
REFERENCES
- 1. Pacak K, Linehan WM, Eisenhofer G, et al. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med. 2001;134(4):315. [DOI] [PubMed] [Google Scholar]
- 2. Beard CM, Sheps SG, Kurland LT, et al. Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc. 1983;58(12):802. [PubMed] [Google Scholar]